SecurityDWCH / Datawatch Corp. (237917208)
Institutional Owners58 (7 N-Q Owners)
Institutional Shares4,828,133 - 39.09% (ex. N-Q)
Common Shares Outstanding12,352,143 shares (as of 2017-12-31)
Institutional Value$ 41,765,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

DWCH / Datawatch Corp. Institutional Ownership

Datawatch Corp. (NASDAQ:DWCH) has 58 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,828,133 shares. Largest shareholders include Renaissance Technologies LLC, Vanguard Group Inc, G2 Investment Partners Management LLC, BlackRock Inc., State of New Jersey Common Pension Fund D, Allianz Asset Management AG, Essex Investment Management Co Llc, VIEX Capital Advisors, LLC, Deutsche Bank Ag\, and Oberweis Asset Management Inc/.
Datawatch Corp. (NASDAQ:DWCH) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/dwch"><img src="https://images.fintel.io/us-dwch-so.png" alt="DWCH / Datawatch Corp. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-14 13F-HR COOPER CREEK PARTNERS MANAGEMENT LLC 103,200 0 -100.00 980 0 -100.00
2018-05-09 13F-HR Teton Advisors, Inc. 28,000 23,000 -17.86 266 199 -25.19
2018-05-15 13F-HR A.R.T. Advisors, LLC 16,340 0 -100.00 155 0 -100.00
2018-04-23 13F-HR Advisory Services Network, LLC 800 0 -100.00 8 0 -100.00
2018-02-09 13F-HR CITADEL ADVISORS LLC 22,773 0 -100.00 263 0 -100.00
2018-05-14 13F-HR MORGAN STANLEY 39,996 25,967 -35.08 380 225 -40.79
2018-05-15 13F-HR UBS Group AG 0 1,558 0 14
2018-04-20 13F-HR Seacrest Wealth Management, Llc 500 0 -100.00 5 0 -100.00
2018-05-15 13F-HR OBERWEIS ASSET MANAGEMENT INC/ 99,300 150,998 52.06 943 1,306 38.49
2018-02-26 N-Q Allianz Funds Multi-strategy Trust (see advisory)
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 0 13,866 0 120
2018-05-15 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 68,738 40,776 -40.68 653 353 -45.94
2018-05-02 13F-HR HARVEST MANAGEMENT LLC 10,000 87
2018-05-14 13F-HR Concourse Capital Management, LLC 0 38,897 0 336
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 64,643 64,643 0.00 614 559 -8.96
2018-05-15 13F-HR Bank of New York Mellon Corp 41,749 55,401 32.70 397 479 20.65
2018-05-15 13F-HR VIEX Capital Advisors, LLC 165,327 1,430
2018-05-14 13F-HR Allianz Asset Management AG 277,394 276,135 -0.45 2,635 2,389 -9.34
2018-02-28 N-Q Ishares Trust (see advisory)
2018-05-10 13F-HR Spark Investment Management LLC 46,600 31,700 -31.97 442 274 -38.01
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 18,110 17,110 -5.52 173 148 -14.45
2018-05-02 13F-HR ALGERT GLOBAL LLC 141,588 100,815 -28.80 1,345 872 -35.17
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 663 663 0.00 6 6 0.00
2018-05-15 13F-HR Invesco Ltd. 23,250 16,250 -30.11 221 141 -36.20
2018-05-11 13F-HR MACQUARIE GROUP LTD 44,220 22,389 -49.37 420 194 -53.81
2018-05-15 13F-HR PDT Partners, LLC 40,500 22,900 -43.46 385 198 -48.57
2018-05-11 13F-HR GSA CAPITAL PARTNERS LLP 27,300 20,200 -26.01 259 175 -32.43
2018-05-09 13F-HR NORTHERN TRUST CORP 26,170 32,561 24.42 249 282 13.25
2018-05-15 13F-HR WOLVERINE TRADING, LLC Call 10,100 0 -100.00 96 0 -100.00
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 0 32,445 0 282
2018-05-15 13F-HR PEAK6 Investments, L.P. Put 3,000 0 -100.00 29 0 -100.00
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 28,755 0 -100.00 273 0 -100.00
2018-04-26 13F-HR ESSEX INVESTMENT MANAGEMENT CO LLC 198,367 184,826 -6.83 1,884 1,599 -15.13
2018-05-14 13F-HR Renaissance Technologies LLC 922,400 965,200 4.64 8,763 8,349 -4.72
2018-05-11 13F-HR Cutler Group LP 1,000 2,331 133.10 9 20 122.22
2018-05-15 13F-HR PEAK6 Investments, L.P. 2,605 0 -100.00 25 0 -100.00
2018-05-08 13F-HR Alambic Investment Management, L.P. 57,734 130,841 126.63 548 1,132 106.57
2018-05-15 13F-HR PUTNAM INVESTMENTS LLC 108,178 936
2018-05-15 13F-HR Squarepoint Ops LLC 10,700 0 -100.00 102 0 -100.00
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 0 6,160 0 53
2018-05-02 13F-HR Trellus Management Company, LLC 23,900 207
2018-05-03 13F-HR Trexquant Investment LP 19,708 23,539 19.44 187 204 9.09
2018-05-14 13F-HR S Squared Technology, LLC 75,000 137,269 83.03 712 1,187 66.71
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 69,222 69,676 0.66 657 601 -8.52
2018-04-27 N-Q Fidelity Concord Street Trust (see advisory)
2018-05-15 13F-HR QS Investors, LLC 640 640 0.00 6 6 0.00
2018-05-11 13F-HR Cutler Group LP Call 400 0 -100.00 0 0
2018-05-15 13F-HR PEAK6 Investments, L.P. Call 18,100 0 -100.00 172 0 -100.00
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 8,394 9,431 12.35 80 82 2.50
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 100 100 0.00 1 1 0.00
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 82,686 79,443 -3.92 786 687 -12.60
2018-04-26 13F-HR SIMPLEX TRADING, LLC 0 17 0 0
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 528 0 -100.00 5 0 -100.00
2018-02-27 N-Q TETON WESTWOOD FUNDS (see advisory)
2018-04-26 13F-HR SIMPLEX TRADING, LLC Put 0 1 0 0
2018-02-14 13F-HR ROYAL BANK OF CANADA 3 0 -100.00 0 0
2018-05-10 13F-HR JP Morgan Chase & Co 0 6,423 0 56
2018-05-15 13F-HR DEUTSCHE BANK AG\ 192,885 162,537 -15.73 1,832 1,405 -23.31
2018-03-29 N-Q Aim Investment Funds (invesco Investment Funds) (see advisory)
2018-02-27 N-Q Northern Funds (see advisory)
2018-05-15 13F-HR OXFORD ASSET MANAGEMENT 79,771 118,075 48.02 726 1,021 40.63
2018-05-01 13F-HR Wealthstreet Investment Advisors, Llc 58,426 58,426 0.00 555 505 -9.01
2018-05-14 13F-HR Connor, Clark & Lunn Investment Management Ltd. 11,527 10,427 -9.54 110 90 -18.18
2018-04-27 N-Q Amg Funds (see advisory)
2018-05-15 13F-HR BARCLAYS PLC 1 0 -100.00 0 0
2018-05-11 13F-HR Russell Investments Group, Ltd. 17,094 0 -100.00 156 0 -100.00
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 24,864 17,077 -31.32 236 148 -37.29
2018-05-11 13F-HR Cutler Group LP Put 0 1,000 0 2
2018-05-11 13F-HR Mutual of America Capital Management LLC 5,000 43
2018-05-15 13F-HR VANGUARD GROUP INC 423,909 439,177 3.60 4,027 3,799 -5.66
2018-05-08 13F-HR State of New Jersey Common Pension Fund D 300,000 280,000 -6.67 2,850 2,422 -15.02
2018-02-09 13F-HR Archon Capital Management LLC 66,353 0 -100.00 766 0 -100.00
2018-05-08 13F-HR THOMPSON SIEGEL & WALMSLEY LLC 8,700 75
2018-05-21 13F-HR/A EAM Investors, LLC 240,709 0 -100.00 2,780 0 -100.00
2018-05-14 13F-HR Royce & Associates LLC 76,103 55,977 -26.45 723 484 -33.06
2018-05-09 13F-HR BlackRock Inc. 310,625 310,554 -0.02 2,951 2,686 -8.98
2018-05-15 13F-HR G2 Investment Partners Management LLC 574,061 391,415 -31.82 5,454 3,386 -37.92
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 87,192 59,193 -32.11 828 512 -38.16

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( DWCH / Datawatch Corp. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

Related News Stories

Datawatch: How Much Longer Do We Keep Waiting?

2018-04-30 seekingalpha
Datawatch, the data analytics company that competes with Alteryx, posted anemic growth in Q2 despite folding in the results of a recently acquired company, Angoss Software. (1-1)

A Pure Play On Self-Service Big Data Prep And Analytics: Wait For Smarter Valuation Entry Point

2018-04-30 seekingalpha
Alteryx, Inc. is well-positioned in the fast-growing big data preparation and predictive analytics market with its easy to use, self-service, full-life-cycle, collaborative and governed platform architecture. (283-2)

Datawatch's (DWCH) CEO Michael Morrison on Q2 2018 Results - Earnings Call Transcript

2018-04-26 seekingalpha
Greetings and welcome to the Datawatch Corporation Second Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. (1-1)

Datawatch's 2018 Material Improvements Forecast A Higher Price?

2018-04-09 seekingalpha
Improved operations, double-digit top-line growth, near-term Swarm enterprise sales, and Angoss all offer strong upside synergies. (23-0)

Datawatch: Deep Discount To Possible Acquisition Value

2018-01-28 seekingalpha
Datawatch has soared in recent weeks on rumors that it has been approached by potential buyers. (115-1)

CUSIP: 237917208